The RNA Pipeline Grants (RPG) is a $6 million, single round, competitive technology development and commercialisation program as part of the NSW Government’s RNA R&D Initiatives, administered by the Office of the Chief Scientist & Engineer (OCSE) within the NSW Premier's Department.

The objectives of the RPG program are to:

support a pipeline of products that could be manufactured at the NSW RNA Research and Manufacturing Facility

progress the development and manufacture of innovative RNA therapeutics, vaccines and related technologies – including applications in health, biosecurity and agriculture - towards commercialisation in NSW

improve commercialisation opportunities for NSW-based start-ups and businesses through targeted support for translation and scale-up

contribute to a globally competitive RNA ecosystem in NSW that delivers long-term economic, scientific, and social benefits, including enhanced workforce capability and sovereign manufacturing capacity.

The RPG will support companies developing innovative RNA therapeutics, vaccines and related technologies within the Technology Readiness Level (TRL) range of 3 – 6, helping them advance along the TRL scale toward commercialisation and manufacturing.

The RPG is part of the broader RNA Program, an initiative of the NSW Government aimed at proactively fostering the growth of a state-based RNA ecosystem. This program reflects the NSW Government’s wider commitment to advancing research and development, and manufacturing in the health, medical, agricultural and biosecurity sectors.

The RPG has $6 million in funding over 2 years for projects ranging between $200,000 to $3 million.

Further information, including program guidelines and an application form, can be found here: https://www.chiefscientist.nsw.gov.au/rna-pipeline-grants